Should Women Make a Profit on Donating Their Eggs For Research?
By Larry Mantle,
KPCC
| 06. 20. 2013
[With CGS's Diane Tober]
[To listen to the full radio segment, go here]
The amount of money a woman can receive for donating eggs could shoot up from hundreds of dollars to thousands if a new law passes the state Senate. The Senate is expected to vote on a bill today that would allow women who donate their eggs for research to be paid over and above “direct expenses”. Fertility researchers complain that there is a shortage of eggs because women don’t have many incentives to go through the often painful procedure. But opponents argue that there’s not enough research into the safety of egg donation and it shouldn’t become a for-profit enterprise.
Guests:
Barbara Collura, President/CEO of Resolve: The National Infertility Association founded in 1974; listed as official support for AB926.
Diane Tober, PhD, Associate Executive Director of the Center for Genetics and Society
Related Articles
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...
By Ian Sample, The Guardian | 03.08.2024
Scientists are a step closer to making IVF eggs from patients’ skin cells after adapting the procedure that created Dolly the sheep, the first cloned mammal, more than two decades ago.
The work raises the prospect of older women being...
By Ramon Antonio Vargas, The Guardian | 02.28.2024
Doctors say a man in California who contracted blood cancer while living with HIV is in remission from both potentially fatal illnesses thanks to a treatment they are hailing as remarkable and encouraging.
Paul Edmonds is only the fifth-known person...
By Victoria Gray, Uduak Thomas, and Kevin Davies, The CRISPR Journal | 02.14.2024
In July 2019, medical staff in Nashville dosed the first U.S. patient in the exa-cel therapy trial, sponsored by Vertex Pharmaceuticals and CRISPR Therapeutics. That first patient was Victoria Gray, a mother of four from Forest, Mississippi, a sickle cell...